CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Income Statement [Abstract]
Licensing revenue	$ 0	$ 0	$ 0	$ 0
Total revenues	0	0	0	0
Operating Expenses:
Research and development	665,717	698,802	1,354,735	1,468,901
Selling, general and administrative	792,761	1,451,585	1,729,388	2,995,084
Impairment charge	0	9,625,000	0	9,625,000
Loss (gain) on disposal of property and equipment	(4,000)	130,594	(4,000)	239,434
Depreciation and amortization	27,509	361,616	58,165	448,320
Total operating expenses	1,481,987	12,267,597	3,138,288	14,776,739
Loss from operations	(1,481,987)	(12,267,597)	(3,138,288)	(14,776,739)
Other Income (Expense):
Gain (loss) on revaluation of derivative liabilities	1,086,999	250,000	761,950	(7,845)
Financing gain (loss)	0	1,177,000	0	(4,357,000)
Loss on early extinguishment of bridge loans	(1,728,235)	0	(2,143,960)	0
Amortization of debt discount	(710,252)	0	(895,218)	0
Interest expense	(107,373)	(2,001)	(146,560)	(4,726)
Other income (expense), net	(1,458,861)	1,424,999	(2,423,788)	(4,369,571)
Net loss	(2,940,848)	(10,842,598)	(5,562,076)	(19,146,310)
Deemed dividend on beneficial conversion feature of preferred stock	(6,460,818)		(6,460,818)
Net loss applicable to common shareholders	$ (9,401,666)	$ (10,842,598)	$ (12,022,894)	$ (19,146,310)
Net loss per common share, basic and diluted	$ (.82)	$ (0.97)	$ (1.06)	$ (1.69)
Basic and diluted weighted average common shares outstanding	11,446,862	11,128,275	11,325,028	11,337,272